Physician profile
Laura T Hetzler
NPI 1740446228
$1,347.94
in general payments reported to CMS, 2019-2025
11 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2021: $185 · 2022: $123 · 2023: $141 · 2024: $156 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $591.94 | 2021-2025 | Stealthstation S8 Platform, Pteye Parathyroid Detection System, Propel |
| Kls-Martin L.P. | $127.51 | 2019 | |
| Optinose US, INC. | $122.80 | 2021 | |
| Axogen | $103.40 | 2025 | |
| Glaxosmithkline, LLC. | $100.00 | 2022 | |
| Smith+Nephew, INC. | $99.42 | 2025 | Ent Sinus |
| Globus Medical, INC. | $52.11 | 2023 | Allocate |
| Acclarent, INC | $51.53 | 2019 | |
| Kerecis Limited | $42.53 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Polynovo North America LLC | $37.78 | 2019 | |
| Acera Surgical, INC. | $18.92 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Hetzler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.